Results 91 to 100 of about 6,793 (233)
In small-cell lung cancer (SCLC), the role of chemotherapy and radiotherapy is well established. Large-cell neuroendocrine carcinoma (LCNEC) shares several clinicopathological features with SCLC, but its optimal therapy is not defined.
Arsela Prelaj +11 more
doaj +1 more source
The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the Lung
Large cell neuroendocrine carcinoma of the lung (LCNEC) is currently classified as a rare lung cancer subtype, but given the high incidence of lung cancer, the overall number of cases is considerable.
Catalin Buium +3 more
doaj +1 more source
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors. [PDF]
PurposeImmune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the results of the (nonpancreatic) neuroendocrine neoplasm cohort of SWOG S1609 dual anti-CTLA-4 and ...
Baghdadi, Tareq Al +21 more
core
ABSTRACT Background Emerging evidence indicates that baseline use of certain concomitant drugs may affect the efficacy of immune checkpoint inhibitors (ICIs), including PD‐1, PD‐L1, and CTLA‐4 inhibitors, in patients with cancer. However, most previous studies have evaluated individual drug classes in isolation, without considering potential ...
Masafumi Saiki +12 more
wiley +1 more source
Background Large cell neuroendocrine tumors of the lung (LCNEC) are rare. Chemotherapy with the small cell lung carcinoma (SCLC) regimen is the most appropriate treatment for LCNEC.
Yutaka Takahara +12 more
doaj +1 more source
ABSTRACT Neuroendocrine tumors (NET) are a heterogeneous group of neoplasms that arise from neuroendocrine cells and commonly originate in the GI tract, lungs, and pancreas, but can also present in the skull base and paranasal sinuses. While fluorodeoxyglucose positron emission tomography (FDG PET) scans are routinely used in the evaluation of ...
Michael Sabbaj +12 more
wiley +1 more source
ABSTRACT Gastric neuroendocrine neoplasms are a rare type of stomach cancer, classified into well‐differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Gastric NETs (G‐NETs) originate from endocrine progenitor cells in the basal layer of the mucosa, primarily in the setting of chronic atrophic gastritis,
Katsunori Matsueda +4 more
wiley +1 more source
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a high-grade neuroendocrine carcinoma (HGNEC) accounting for 3% of primary lung cancer, and characterized by strong invasion, high heterogeneity, and extremely poor prognosis.
Siyu Zhu +10 more
doaj +1 more source
This review provides an overview of the key cytopathological features defining the ‘Malignant’ category of the World Health Organization's Reporting System for Lung Cytopathology and discusses the application of ancillary techniques in cytological specimens from the lung, including immunocytochemistry and molecular testing.
Magdalena M. Brune +3 more
wiley +1 more source
ABSTRACT Background The COVID‐19 pandemic reintroduced single‐fraction radiotherapy for symptomatic bone metastases due to its efficiency, rapid realization, and cost‐effectiveness. However, pain flare can occur as a side effect that can have a significant impact on a patient's quality of life.
Tatjana Arsenijević +4 more
wiley +1 more source

